Evidence map›Paper›PMID 36053649›Full record

ArticleBMJ paediatrics open2022

Early surfactant and non-invasive ventilation versus intubation and surfactant: a propensity score-matched national study.

Hallvard Reigstad, Karl Ove Hufthammer, Arild E Rønnestad, Claus Klingenberg, Hans Jørgen Stensvold, Trond Markestad, Norwegian Neonatal Network

Open access · diamondAbstract read
In one paragraph

Article in BMJ paediatrics open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hallvard ReigstadDepartment of Pediatrics, Haukeland University Hospital, Bergen, Norway hallvard.reigstad@helse-bergen.no.ORCID 0000-0003-0470-768X
Karl Ove HufthammerCentre for Clinical Research, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0003-3170-9496
Arild E RønnestadWomen and Children's division, Department of Neonatal Intensive Care, Rikshospitalet, Oslo Universitetssykehus, Oslo, Norway.
Claus KlingenbergDepartment of Paediatrics, University Hospital of North Norway, Tromso, Norway.
Hans Jørgen StensvoldNeonatal Department, Oslo University Hospital, Oslo, Norway.
Trond MarkestadDepartment of Clinical Science, Universitetet i Bergen Det medisinske fakultet, Bergen, Norway.ORCID 0000-0002-4725-1769
Norwegian Neonatal Network
Haukeland University Hospital · NOOslo University Hospital · NOInnlandet Hospital Trust · NOUniversity Hospital of North Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare outcome after less invasive surfactant administration (LISA) and primary endotracheal intubation (non-LISA) in infants born before gestational age (GA) 28 weeks.

settingAll neonatal intensive care units (NICUs) in Norway during 2012-2018.

methodsDefined population-based data were prospectively entered into a national registry. We compared LISA infants with all non-LISA infants and with non-LISA infants who received surfactant following intubation. We used propensity score (PS) matching to identify non-LISA infants who were similar regarding potential confounders. MAIN OUTCOME VARIABLES: Rate and duration of mechanical ventilation (MV), survival, neurological and gastrointestinal morbidity, and need of supplemental oxygen or positive pressure respiratory support at postmenstrual age (PMA) 36 and 40 weeks.

resultsWe restricted analyses to GA 25-27 weeks (n=843, 26% LISA) because LISA was rarely used at lower GAs. There was no significant association between NICUs regarding proportions treated with LISA and proportions receiving MV. In the PS-matched datasets, fewer LISA infants received MV (61% vs 78%, p<0.001), and they had fewer days on MV (mean difference 4.1, 95% CI 0.0 to 8.2 days) and lower mortality at PMA 40 weeks (absolute difference 6%, p=0.06) compared with all the non-LISA infants, but only a lower rate of MV (64% vs 97%, p<0.001) and fewer days on MV (mean difference 5.8, 95% CI 0.6 to 10.9 days) compared with non-LISA infants who received surfactant after intubation.

conclusionLISA reduced the rate and duration of MV but had no other clear benefits.

Indexed as

Noninvasive VentilationPulmonary SurfactantsHumansInfantInfant, NewbornInfant, PrematureIntubation, IntratrachealLipoproteinsPropensity ScoreRespiration, ArtificialSurface-Active AgentsLipoproteinsPulmonary SurfactantsSurface-Active Agentsneonatology

Identifiers

PMID36053649
PMCPMC9335034
OpenAlexW4288075205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.